HERBALIFE LTD. Net Change in Cash
HERBALIFE LTD. (HLF) reported Net Change in Cash of $18.10 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-08-05
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2026-03-31 was $97.70M.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2025-03-31 was -$87.10M.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2024-03-31 was -$183.00M.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2023-03-31 was -$54.50M.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2025 was -$62.80M.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2024 was -$157.40M, a 298.74% decline from fiscal 2023.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2023 was $79.20M.
- HERBALIFE LTD. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$94.10M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $18.10M 10-Q · filed 2026-08-05 | |||
| 2026-03-31 | $97.70M 10-Q · filed 2026-05-06 | |||
| 2025-12-31 | -$62.80M 10-K · filed 2026-02-18 | |||
| 2025-09-30 | -$110.10M 10-Q · filed 2025-11-05 | |||
| 2025-06-30 | -$94.50M 10-Q · filed 2026-08-05 | |||
| 2025-03-31 | -$87.10M 10-Q · filed 2026-05-06 | |||
| 2024-12-31 | -$157.40M 10-K · filed 2026-02-18 | |||
| 2024-09-30 | -$177.60M 10-Q · filed 2025-11-05 | |||
| 2024-06-30 | -$206.20M 10-Q · filed 2025-08-06 | |||
| 2024-03-31 | -$183.00M 10-Q · filed 2025-04-30 | |||
| 2023-12-31 | $79.20M 10-K · filed 2026-02-18 | |||
| 2023-09-30 | -$300.00K 10-Q · filed 2024-10-30 | |||
| 2023-06-30 | $31.00M 10-Q · filed 2024-07-31 | |||
| 2023-03-31 | -$54.50M 10-Q · filed 2024-05-01 | |||
| 2022-12-31 | -$94.10M 10-K · filed 2025-02-19 | |||
| 2022-09-30 | -$69.70M 10-Q · filed 2023-11-01 | |||
| 2022-06-30 | -$20.50M 10-Q · filed 2023-08-02 | |||
| 2022-03-31 | -$31.80M 10-Q · filed 2023-05-02 | |||
| 2021-12-31 | -$443.60M 10-K · filed 2024-02-14 | |||
| 2021-09-30 | -$367.00M 10-Q · filed 2022-10-31 | |||
| 2021-06-30 | -$207.70M 10-Q · filed 2022-08-02 | |||
| 2021-03-31 | -$433.70M 10-Q · filed 2022-05-03 | |||
| 2020-12-31 | $206.50M 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $195.40M 10-Q · filed 2021-11-02 | |||
| 2020-06-30 | $900.60M 10-Q · filed 2021-08-03 | |||
| 2020-03-31 | $104.60M 10-Q · filed 2021-05-04 | |||
| 2019-12-31 | -$367.50M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | -$491.80M 10-Q · filed 2020-11-05 | |||
| 2019-06-30 | $47.30M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | $4.00M 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | -$80.50M 10-K · filed 2021-02-17 | |||
| 2018-09-30 | -$169.20M 10-Q · filed 2019-10-29 | |||
| 2018-06-30 | -$440.40M 10-Q · filed 2019-08-01 | |||
| 2018-03-31 | $51.50M 10-Q · filed 2019-05-02 | |||
| 2017-12-31 | $438.60M 10-K · filed 2020-02-18 | |||
| 2017-09-30 | $796.00M 10-Q · filed 2018-10-30 | |||
| 2017-06-30 | $782.40M 10-Q · filed 2018-08-01 | |||
| 2017-03-31 | $940.70M 10-Q · filed 2018-05-03 | |||
| 2016-12-31 | -$47.50M 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |